|Bid||290.78 x 800|
|Ask||291.09 x 1000|
|Day's Range||290.61 - 294.15|
|52 Week Range||137.01 - 298.31|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||115.14|
|Earnings Date||May 03, 2021|
|Forward Dividend & Yield||2.12 (0.72%)|
|Ex-Dividend Date||Feb 25, 2021|
|1y Target Est||295.50|
(Bloomberg) -- Estee Lauder Cos. agreed to pay $1 billion to boost its stake in Deciem Inc., giving the Canadian skin-care company an enterprise value of $2.2 billion as the cosmetics giant moves toward a full takeover.Estee Lauder will raise its stake in Deciem to 76% from 29% with the deal, which it expects to close in the quarter ending June 30, the New York-based company said in a statement Tuesday. Estee Lauder agreed to buy the rest of Deciem after three years.Deciem had sales of $460 million in the year ended Jan. 31, Estee Lauder said, describing the company as “an industry disruptor with a consumer-focused approach.”Brandon Truaxe, who died two years ago at the age of 40, founded Deciem in 2013. The Toronto-based company attracted a cult following, including Kim Kardashian, after launching The Ordinary, a line of products with familiar ingredients priced at under $10. Estee Lauder invested an undisclosed amount in the company in 2016 and its portfolio grew.A couple of months before he died, Truaxe told staff that he was shutting down Deciem until further notice, citing “major criminal activity” by employees. Estee Lauder took legal action against Truaxe. An Ontario judge ousted him as chief executive officer and forced him from Deciem’s board.There was no hint of that past rancor in the Tuesday statement. “Brandon dreamed of ELC being the forever home for Deciem, and we are truly humbled to achieve his vision today,” said co-founder Nicola Kilner, the current CEO.Skin care continues to be the growth driver for Estee Lauder as makeup sales shrink, accounting for 58% of the company’s revenue in its most recent quarter. Shoppers have gravitated toward self-care items like moisturizer and serums but have seen little need for foundation and lipstick as coronavirus restrictions keep them at home.Estee Lauder shares were down 0.2% to $284.95 at 9:39 a.m. in New York. They are up 7.1% this year and gained 29% last year.(Updates with shares in final paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Estée Lauder Companies Inc. said Tuesday it is increasing its stake in Deciem Beauty Group to 76% from 29% in a first phase, and has agreed to purchase the remaining interests after a three-year period. The company will pay $1 billion in the first phase, which values Deciem at $2.2 billion. That deal is expected to close in the June 30 quarter. Deciem is known as the "Abnormal Beauty Company," and was founded in 2013 by the late Brandon Truaxe. The company has six brands, including The Ordinary, a skin care brand that has created buzz on social media. The company had sales of about $460 million in the 12 months to Jan. 31. The purchase price for Phase 2 will be determined based on the company's future performance. Shares were not active premarket, but have gained 36% in the last 12 months, while the S&P 500 has gained 26%.
The M.A.C brand owner, which is raising its stake to about 76% from about 29%, said it had agreed to purchase the remaining interest in the company after a three-year period. The company net sales and earnings would have a negligible impact on Estee Lauder's fiscal year 2021 consolidated results, the company said.